Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05746533 · ClinicalTrials.gov registry record

An Evaluation of Hip Preservation Outcomes

A clinical trial of Hip Arthroscopy and Femoroacetabular Impingement, sponsored by Yale University.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT05746533: Recruiting study of Hip Arthroscopy and Femoroacetabular Impingement, sponsored by Yale University.

NCT05746533 is a study of Hip Arthroscopy and Femoroacetabular Impingement that is actively recruiting participants, run by Yale University. The registered enrollment target is 10,000 participants, above the 127-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (7774% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05746533, a study of Hip Arthroscopy and Femoroacetabular Impingement, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess outcomes of hip preservation surgeries including open and arthroscopic treatment of femoroacetabular impingement (FAI).

Primary Outcome

iHOT-12 is a 12-item questionnaire scored using a visual analog scale from 0 to 100, with a score of 100 being the best function and least amount of symptoms, and the overall mean equates to the final iHOT score.

Interventions

  • PROCEDURE Hip Arthroscopy

Study Locations (1)

Connecticut

  • Yale New Haven Health - New Haven

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2023-06-02
Est. Completion 2053-06
Yale University

1,492 total trials

What NCT05746533 shows while recruiting

NCT05746533 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 127-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (7774% higher).

The record links to 2 conditions, with Hip Arthroscopy appearing as the primary indexed condition, and to 1 intervention - of which Hip Arthroscopy is the first listed.

NCT05746533 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT05746533 about?

NCT05746533 is a clinical study titled "An Evaluation of Hip Preservation Outcomes". The purpose of this study is to assess outcomes of hip preservation surgeries including open and arthroscopic treatment of femoroacetabular impingement (FAI).

What is the current status of trial NCT05746533?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2023-06-02. Estimated completion is 2053-06.

What conditions does trial NCT05746533 study?

This clinical trial studies the following conditions: Hip Arthroscopy, Femoroacetabular Impingement.

What interventions are being tested in trial NCT05746533?

The interventions under investigation include: Hip Arthroscopy (PROCEDURE).

Who is sponsoring clinical trial NCT05746533?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05746533 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Arthroscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05746533's enrollment target sits among peer trials

10,000 1st of 10 higher than 10 of 10 other Hip Arthroscopy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hip Arthroscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05746533, the US trial registry maintained by the National Library of Medicine. NCT05746533 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.